COSMOS Pharmaceutical Corporation (CSMYF)
USD 46.06
(-0.22%)
USD 46.06
(-0.22%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 23.38 Billion JPY | 133.43% |
| 2023 | 13.71 Billion JPY | 115.76% |
| 2022 | 6.35 Billion JPY | -13.5% |
| 2021 | 7.34 Billion JPY | -18.61% |
| 2020 | 9.02 Billion JPY | -15.6% |
| 2019 | 10.69 Billion JPY | -12.11% |
| 2018 | 12.17 Billion JPY | -21.49% |
| 2017 | 15.5 Billion JPY | -22.86% |
| 2016 | 20.09 Billion JPY | 71.29% |
| 2015 | 11.73 Billion JPY | 167.29% |
| 2014 | 4.39 Billion JPY | 125.01% |
| 2013 | 1.95 Billion JPY | -30.4% |
| 2012 | 2.8 Billion JPY | -35.71% |
| 2011 | 4.36 Billion JPY | -34.51% |
| 2010 | 6.65 Billion JPY | -8.2% |
| 2009 | 7.25 Billion JPY | 27.81% |
| 2008 | 5.67 Billion JPY | 17.3% |
| 2007 | 4.83 Billion JPY | 74.49% |
| 2006 | 2.77 Billion JPY | -40.01% |
| 2005 | 4.62 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 7.96 Billion JPY | -7.93% |
| 2024 Q4 | 23.38 Billion JPY | 193.71% |
| 2024 FY | 23.38 Billion JPY | 70.49% |
| 2024 Q2 | 8.64 Billion JPY | -7.34% |
| 2024 Q1 | 9.33 Billion JPY | -6.84% |
| 2023 Q3 | 2.02 Billion JPY | -13.83% |
| 2023 FY | 13.71 Billion JPY | 115.76% |
| 2023 Q4 | 13.71 Billion JPY | 577.33% |
| 2023 Q2 | 2.35 Billion JPY | -12.15% |
| 2023 Q1 | 2.67 Billion JPY | -57.92% |
| 2022 Q4 | 6.35 Billion JPY | 105.06% |
| 2022 Q3 | 3.1 Billion JPY | -8.82% |
| 2022 FY | 6.35 Billion JPY | -13.5% |
| 2022 Q1 | 3.71 Billion JPY | -49.44% |
| 2022 Q2 | 3.4 Billion JPY | -8.5% |
| 2021 Q4 | 7.34 Billion JPY | 64.81% |
| 2021 Q1 | 5.2 Billion JPY | -42.37% |
| 2021 Q3 | 4.45 Billion JPY | -7.7% |
| 2021 Q2 | 4.83 Billion JPY | -7.15% |
| 2021 FY | 7.34 Billion JPY | -18.61% |
| 2020 Q4 | 9.02 Billion JPY | 51.85% |
| 2020 FY | 9.02 Billion JPY | -15.6% |
| 2020 Q1 | 6.68 Billion JPY | -37.47% |
| 2020 Q2 | 6.31 Billion JPY | -5.55% |
| 2020 Q3 | 5.94 Billion JPY | -5.89% |
| 2019 Q1 | 8.17 Billion JPY | -32.83% |
| 2019 Q4 | 10.69 Billion JPY | 43.93% |
| 2019 FY | 10.69 Billion JPY | -12.11% |
| 2019 Q2 | 7.8 Billion JPY | -4.54% |
| 2019 Q3 | 7.43 Billion JPY | -4.77% |
| 2018 FY | 12.17 Billion JPY | -21.49% |
| 2018 Q2 | 9.81 Billion JPY | -7.62% |
| 2018 Q1 | 10.62 Billion JPY | -31.46% |
| 2018 Q4 | 12.17 Billion JPY | 35.14% |
| 2018 Q3 | 9 Billion JPY | -8.24% |
| 2017 Q4 | 15.5 Billion JPY | 20.48% |
| 2017 FY | 15.5 Billion JPY | -22.86% |
| 2017 Q3 | 12.86 Billion JPY | -8.02% |
| 2017 Q2 | 13.99 Billion JPY | -7.42% |
| 2017 Q1 | 15.11 Billion JPY | -24.81% |
| 2016 Q1 | 7.17 Billion JPY | -38.86% |
| 2016 FY | 20.09 Billion JPY | 71.29% |
| 2016 Q4 | 20.09 Billion JPY | 15.8% |
| 2016 Q3 | 17.35 Billion JPY | -6.07% |
| 2016 Q2 | 18.47 Billion JPY | 157.56% |
| 2015 Q2 | 4.4 Billion JPY | -11.39% |
| 2015 Q3 | 7.59 Billion JPY | 72.22% |
| 2015 Q4 | 11.73 Billion JPY | 54.54% |
| 2015 FY | 11.73 Billion JPY | 167.29% |
| 2015 Q1 | 4.97 Billion JPY | 13.35% |
| 2014 Q2 | 1.99 Billion JPY | 1638.26% |
| 2014 Q3 | 1.73 Billion JPY | -13.21% |
| 2014 FY | 4.39 Billion JPY | 125.01% |
| 2014 Q1 | 115 Million JPY | -94.11% |
| 2014 Q4 | 4.39 Billion JPY | 153.03% |
| 2013 Q4 | 1.95 Billion JPY | 515.46% |
| 2013 Q2 | 543 Million JPY | -37.51% |
| 2013 FY | 1.95 Billion JPY | -30.4% |
| 2013 Q1 | 869 Million JPY | -69.0% |
| 2013 Q3 | 317 Million JPY | -41.62% |
| 2012 FY | 2.8 Billion JPY | -35.71% |
| 2012 Q3 | 1.52 Billion JPY | -22.28% |
| 2012 Q2 | 1.95 Billion JPY | -18.56% |
| 2012 Q4 | 2.8 Billion JPY | 84.29% |
| 2012 Q1 | 2.4 Billion JPY | -44.89% |
| 2011 Q2 | 3.99 Billion JPY | -14.33% |
| 2011 FY | 4.36 Billion JPY | -34.51% |
| 2011 Q4 | 4.36 Billion JPY | 25.79% |
| 2011 Q3 | 3.46 Billion JPY | -13.18% |
| 2011 Q1 | 4.66 Billion JPY | -30.0% |
| 2010 Q3 | 6.04 Billion JPY | 0.0% |
| 2010 FY | 6.65 Billion JPY | -8.2% |
| 2010 Q4 | 6.65 Billion JPY | 10.22% |
| 2009 Q3 | 6.96 Billion JPY | 10.68% |
| 2009 FY | 7.25 Billion JPY | 27.81% |
| 2009 Q2 | 6.29 Billion JPY | 0.0% |
| 2009 Q4 | 7.25 Billion JPY | 4.15% |
| 2008 FY | 5.67 Billion JPY | 17.3% |
| 2007 FY | 4.83 Billion JPY | 74.49% |
| 2006 FY | 2.77 Billion JPY | -40.01% |
| 2005 FY | 4.62 Billion JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 312.15 Thousand USD | -7491274.588% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 21.25 Thousand USD | -110036602.428% |
| Café Serendipity Holdings, Inc. | - USD | -Infinity% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 254.07 Thousand USD | -9204020.108% |
| HealthWarehouse.com, Inc. | 2.63 Million USD | -888677.91% |
| LIGAND PHARMACEUTICAL INC | 5.75 Million USD | -406242.311% |
| MedGen, Inc. | - USD | -Infinity% |
| Omni Health, Inc. | 495.57 Thousand USD | -4718632.47% |
| Oxford Investments Holdings Inc. | - USD | -Infinity% |
| Pineapple, Inc. | - USD | -Infinity% |
| ScripsAmerica, Inc. | 1.06 Million USD | -2187902.616% |